A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

The SPEAR UltraDetect ™ Parallel Plex Solution enables simultaneous biomarker detection without sacrificing analytical performance. The parallel plex approach, which leverages the platform's low ...

Comparative Analysis of Generative Pre-Trained Transformer Models in Oncogene-Driven Non–Small Cell Lung Cancer: Introducing the Generative Artificial Intelligence Performance Score This ...

The global multiomics market, valued at $3.41 billion in 2025, is forecast to reach $12.82 billion by 2036, growing at a 13.31% CAGR from 2026 to 2036. Growth is driven by precision medicine, ...

Stakeholder Perspectives on Provider-Initiated Clinical Breast Examination and Patient Navigation in Ethiopian General Hospitals: Situational Analysis for Implementation Study Biomarkers estrogen ...

Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...

New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...

Recently validated markers have helped improve treatment but more are needed ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving ...